Advertisement
New Zealand markets closed

  • NZX 50

    11,796.21
    -39.83 (-0.34%)
     

  • NZD/USD

    0.5892
    -0.0013 (-0.22%)
     

  • NZD/EUR

    0.5533
    -0.0012 (-0.22%)
     

  • ALL ORDS

    7,817.40
    -81.50 (-1.03%)
     

  • ASX 200

    7,567.30
    -74.80 (-0.98%)
     

  • OIL

    83.70
    +0.97 (+1.17%)
     

  • GOLD

    2,405.40
    +7.40 (+0.31%)
     

  • NASDAQ

    17,394.31
    -99.31 (-0.57%)
     

  • FTSE

    7,832.48
    -44.57 (-0.57%)
     

  • Dow Jones

    37,775.38
    +22.07 (+0.06%)
     

  • DAX

    17,649.01
    -188.39 (-1.06%)
     

  • Hang Seng

    16,220.67
    -165.20 (-1.01%)
     

  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     

  • NZD/JPY

    90.9610
    -0.2930 (-0.32%)
     

Company News For Jun 29, 2018

Zacks Equity Research
Updated
BancorpSouth (BXS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

  • Bed Bath & Beyond Inc. BBBY shares plummeted 3.8% after the company reported that its  fiscal first-quarter 2018 same store sales dropped 0.6% year over year

  • McCormick & Co. Inc. MKC surged 8.4% after posting fiscal second-quarter 2018 adjusted earnings per share of $1.02 outpacing the Zacks Consensus Estimate of $0.93

  • Accenture plc’s  ACN shares soared 5.9% after reporting fiscal third-quarter 2018 adjusted earnings per share of $1.79 surpassing the Zacks Consensus Estimate of $1.71

  • Shares of Progress Software Corp. PRGS jumped 17.6% after posting fiscal second-quarter 2018 adjusted earnings per share of $0.50 beating the Zacks Consensus Estimate of $0.44


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Progress Software Corporation (PRGS) : Free Stock Analysis Report
 
McCormick & Company, Incorporated (MKC) : Free Stock Analysis Report
 
Bed Bath & Beyond Inc. (BBBY) : Free Stock Analysis Report
 
Accenture PLC (ACN) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.